Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes: Part 1

Shuai Hao1, Guillermo E Umpierrez2, Tanicia Daley1

  • 1Division of Pediatric Endocrinology, Children's Healthcare of Atlanta, Emory University School of Medicine, 1400 Tullie Road Northeast, Atlanta, GA 30329, USA.

Insights

Type 2 diabetes in youth rapidly impairs pancreatic beta-cell function. Intensive therapies may temporarily delay decline, but remission is challenging with current medications.

Area of Science:

  • Endocrinology
  • Metabolic disorders
  • Diabetes research

Background:

  • Type 2 diabetes involves progressive pancreatic beta-cell dysfunction.
  • Adults with type 2 diabetes may delay beta-cell decline with intensive therapy, but benefits cease upon treatment withdrawal.
  • Youth with type 2 diabetes exhibit faster beta-cell function loss than adults, even with medication.

Purpose of the Study:

  • To review studies on achieving diabetes remission in youth.
  • To evaluate the efficacy of insulin and oral antidiabetic medications in preserving beta-cell function.

Main Methods:

  • Review of existing studies on type 2 diabetes treatment in youth.
  • Analysis of therapeutic strategies involving insulin and oral antidiabetic agents.

Main Results:

  • Youth with type 2 diabetes show accelerated beta-cell decline compared to adults.
  • Current antihyperglycemic medications, including insulin, do not prevent beta-cell loss in this population.
  • Therapeutic improvements are often temporary and lost upon cessation.

Conclusions:

  • Achieving sustained diabetes remission in youth with type 2 diabetes remains a significant challenge.
  • Further research is needed to develop effective long-term strategies for preserving beta-cell function in pediatric populations.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
326
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
224
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K